Pan-immune inflammation value: A novel biomarker for cataract.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41171769.
- Also identified by DOI 10.1371/journal.pone.0335713 and PMC identifier 12578218.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inflammation significantly contributes to cataract formation; Pan-immune inflammation value (PIV) is an emerging marker that may reflect systemic inflammation. This study aimed to explore the connection between PIV and cataract formation. We analyzed 8,235 participants from the National Health and Nutrition Examination Survey (NHANES) between 2005 and 2008. PIV was log-transformed, and weighted logistic regression, restricted cubic splines (RCS), subgroup, and sensitivity analyses were performed to evaluate associations. The receiver operating characteristic (ROC) curves were used to assess predictive performance. Cataract prevalence was 6.6%. Higher ln-PIV was positively associated with cataract prevalence [OR=1.35, 95%CI: 1.08-1.69, P = 0.015]. The association was linear, consistent across subgroups, and robust in sensitivity analyses. The ROC analysis indicated that PIV had better predictive ability for cataract than other inflammatory indices. We found that higher PIV levels were positively associated with cataract prevalence, which highlights the value of inflammatory markers in assessing cataract development and provides new ideas for the clinical detection of cataracts.
Medical subject headings
- Cataract
- Biomarkers
- Inflammation